DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Folgen

1. Introducing DrugChatter: Revolutionizing Information Access

   Vom: 25.6.2024
2. USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry

   Vom: 25.6.2024
3. Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents

   Vom: 24.6.2024
4. The Intricate Journey of Drug Patents: From Filing to Expiry

   Vom: 20.6.2024
5. Uncovering Lucrative Low-Competition Generic Drug Opportunities

   Vom: 19.6.2024
6. Maximizing ROI with Branded Generics: A Comprehensive Guide

   Vom: 18.6.2024
7. A Practical Guide to FtO Analysis for Drug Repurposing Ventures

   Vom: 17.6.2024
8. Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

   Vom: 17.6.2024
9. Innovative Approaches to Extend the Life of Drug Patents

   Vom: 17.6.2024
10. How long does a patent last for drugs?

    Vom: 12.6.2024
11. Crucial Insights on Patent Litigation Strategies in Pharma Industry

    Vom: 10.6.2024
12. Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

    Vom: 6.6.2024
13. Innovative Strategies in Drug Repurposing

    Vom: 23.4.2024
14. AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

    Vom: 16.4.2024
15. Innovative Financing Models for Repurposing Generic Drugs

    Vom: 11.4.2024
16. Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

    Vom: 31.3.2024
17. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Vom: 22.3.2024
18. LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

    Vom: 8.3.2024
19. GELATIN-Free Medicines: Which Drugs Contain GELATIN?

    Vom: 6.3.2024
20. Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

    Vom: 26.2.2024